S&P 500
5,963.60
+0.1%
+5.22
DJI
42,792.07
+0.3%
+137.33
NASDAQ
19,215.46
+0.0%
+4.36
Bitcoin
105,368.00
+0.2%
+192.60
AAPL
$208.66
-1.2%
-$2.60
AMZN
$205.97
+0.2%
+$0.38
GOOG
$167.77
+0.2%
+$0.34
META
$640.00
-0.1%
-$0.34
MSFT
$458.29
+0.9%
+$4.02
NVDA
$135.42
+0.0%
+$0.02
TSLA
$341.81
-2.3%
-$8.17
Harrow (NASDAQ: HROW)
$28.29
(-0.4%)
-$0.12
Price as of May 19, 2025, 3:58 p.m. ET
Harrow Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Harrow Company Info
Harrow Health, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development.The Pharmaceutical Compounding segment focuses on the operations of ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
News & Analysis
Featured Article
Why Shares of Harrow Health Are Jumping Wednesday
The company increased guidance, acquired a company, and had a stock sale.
Jim Halley | Jul 19, 2023
Featured Article
Why Shares of Harrow Health Are Slumping Friday
The pharmaceutical company announced first-quarter earnings Thursday afternoon.
Jim Halley | May 12, 2023
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.